Help us: Donate
Follow us on:
×

Ending Age-Related Diseases: 2018

BRINGING REJUVENATION BIOTECHNOLOGY AND INVESTORS TOGETHER

At the Frederick P. Rose Auditorium, Cooper Union in New York City, we will be hosting a special one-day conference focused on aging research and biotech investment. Developing therapies from initial concepts, through clinical testing, and ultimately to market takes a pipeline, and right now, that pipeline is being built to support the next step in medicine: rejuvenation biotechnology. Join us for this exciting event, where industry experts will be sharing their insights on the advances and investment prospects in an industry poised to revolutionize medicine forever.

OFFICIAL EVENT SPONSORS

INDUSTRY EXPERTS FROM RESEARCH AND INVESTMENT

We bring you insights from the leading experts in research and biotech investment, who will guide you through the industry in a series of talks and presentations. Below are the confirmed guests, and we will be announcing more speakers soon, so be sure to check back with us often to see who else will be joining us.

Aubrey de Grey, Ph.D.

SENS Research Foundation - CSO

James Peyer, Ph.D.

Cambrian BioPharma - CEO

Oliver Medvedik, Ph.D.

Lifespan.io - Vice President

Vadim Gladyshev, Ph.D.

Harvard Medical School - Professor, Medicine, Harvard Medical School

Ramphis Castro

ScienceVest - Partner

Bobby Brooke

Intervene Immune - CEO

Mark Hammond, Ph.D.

Deep Science Ventures - Director

Sudhir Paul, Ph.D.

Covalent Bioscience - Co-founder

Keith Comito

Lifespan.io - President

Vera Gorbunova, Ph.D.

University of Rochester - Professor of Biology

Steven A. Garan

Center for Research & Education on Aging - Director of Bioinformatics

Stephen Hilbert

Oisin Biotechnologies - CBO

Alvaro Macieira-Coelho, Ph.D.

French Institute of Health and Medical Research - INSERM

Reason

Repair Biotechnologies
[/team_member]

Michael West, Ph.D.

AgeX Therapeutics - CEO

Kelsey Moody, Ph.D.

Ichor Therapeutics - CEO

Antonei Csoka, Ph.D.

Howard University - Associate Professor

EVENT PROGRAM

We have a feature-packed event program planned for you to enjoy, and it will include an overview of progress in the field, prospects for translational research, venture philanthropy, policy and regulation insights, and the challenges that the industry faces.